search icon

    Market Snapshot

    • S&P Futures

      3,779.5

    • Dow Futures

      30,569

    • Nasdaq Futures

      11,622.75

    blog search icon

    AVROBIO, Inc.

    (NASDAQ:AVRO)

    $0.94

    $0.02

    1.98%

    AVROBIO, Inc. Chart

    AVRO Stock Price Today

    AVROBIO, Inc. (AVRO) stock rallied over 1.98% intraday to trade at $0.94 a share on NASDAQ. The stock opened with a gain of 2.17% at $0.928 and touched an intraday high of $0.97, rising 2.17% against the last close of $0.92. The stock went to a low of $0.92 during the session.

    Stock Snapshot

    $0.92

    Prev. Close

    41 Million

    Market Cap

    $0.92

    Day Low

    $0.928

    Open

    43.7 Million

    Number of Shares

    $0.97

    Day High

    -

    P/E ratio

    -2.81

    EPS (TTM)

    4.40

    Cash Flow per Share

    3.98

    Free Float in %

    4.44

    Book Value

    201,584

    Volume

    AVROBIO, Inc. Historical Data

    DateOpenHighLowCloseVolume
    2022-07-05$0.928$0.97$0.92$0.938176,593
    2022-07-01$0.92$0.97$0.91$0.92228,700
    2022-06-30$0.98$1$0.92$0.92309,200
    2022-06-29$0.99$1.02$0.96$1.01474,100
    2022-06-28$1.02$1.03$0.95$0.96462,800
    2022-06-27$1$1.02$0.96$1118,300
    2022-06-24$1$1.03$0.95$0.984,657,700
    2022-06-23$0.96$1.02$0.94$1.01537,300
    2022-06-22$0.94$1$0.92$0.95485,700
    2022-06-21$0.95$0.97$0.92$0.94235,100

    Contact Details

    Building 300
    Suite 201 One Kendall Square
    Cambridge, MA 02139
    United States

    Webiste:AVRO

    617 914 8420

    Company Information

    Employees-

    Beta1.61

    Sales or Revenue0

    5Y Sales Change-

    Fiscal Year Ends2021-12-30

    SectorHealth Care

    IndustryBiotechnology

    About Company

    AVROBIO, Inc., a clinical-stage gene therapy company, develops ex vivo lentiviral-based gene therapies to treat rare diseases following a single dose worldwide. Its gene therapies employ hematopoietic stem cells that are collected from patients and modified with a lentiviral vector to insert functional copies of the gene that is defective in the target disease. The company's product includes AVR-RD-01, a gene therapy for the treatment of Fabry disease. It is also developing AVR-RD-02, which is in phase 1/2 clinical trial for the treatment of type 1 Gaucher disease; AVR-RD-03, for the treatment of Pompe disease; AVR-RD-04 for the treatment of cystinosis; AVR-RD-05 for the treatment of Hunter syndrome; and AVR-RD-06 that is in preclinical stage for the treatment of Gaucher disease type 3. The company was incorporated in 2015 and is headquartered in Cambridge, Massachusetts.

    Frequently Asked Questions

    icon

    What is the current AVROBIO, Inc. (AVRO) stock price?

    AVROBIO, Inc. (NASDAQ: AVRO) stock price is $0.94 as of the last check on Tuesday, July 5. During the trading session, AVRO stock reached the peak price of $0.97 while $0.92 was the lowest point it dropped to.

    icon

    AVRO's industry and sector of operation?

    The NASDAQ listed AVRO is part of Biotechnology industry that operates in the broader Health Care sector. AVROBIO, Inc. , a clinical-stage gene therapy company, develops ex vivo lentiviral-based gene therapies to treat rare diseases following a single dose worldwide.

    icon

    Who are the executives of AVRO?

    Mr. Kim Raineri M.B.A.
    Chief Manufacturing & Technology Officer
    Ms. Georgette Verdin
    Chief HR Officer
    Mr. Geoff MacKay BSc
    Co- Founder, Pres, CEO & Director
    Mr. Erik John Ostrowski M.B.A.
    CFO & Treasurer

    icon

    What is the AVRO stock price today?

    AVRO stock traded closed the last session at $0.938, which is $0.02 or 1.98% lower than its previous close of $0.92. AVRO's current trading price is 26.80% lower than its 52-week high of $9.37 where as its distance from 52-week low of 0.74% is -89.99%.

    icon

    How many employees does AVRO have?

    Number of AVRO employees currently stands at -. AVRO operates from Building 300, Suite 201 One Kendall Square, Cambridge, MA 02139, United States.

    icon

    Link for AVRO official website?

    Official Webiste of $AVRO is: https://www.avrobio.com

    icon

    How do I contact AVRO?

    AVRO could be contacted at AVRO operates from Building 300, Suite 201 One Kendall Square, Cambridge, MA 02139, United States, or at phone #617 914 8420 and can also be accessed through its website.

    icon

    How many shares of AVRO are traded daily?

    AVRO stock volume for the day was 201,584 shares while in the previous session number of AVRO shares traded was 176,593 . The average number of AVRO shares traded daily for last 3 months was 506.41 Thousands.

    icon

    How much did AVRO change today?

    The percentage change in AVRO stock occurred in the recent session was 1.98% while the dollar amount for the price change in AVRO stock was $0.02.

    icon

    What price range AVRO stock been trading in?

    In the recent session, the day high for AVRO stock was $0.97 while the low for AVRO stock touched on the day was $0.92.

    icon

    What is the market cap of AVRO currently?

    The market value of AVRO currently stands at 41 Million with its latest stock price at $0.94 and 43.7 Million of its shares outstanding.